Australia's Emyria rises on depression treatment programme deal with Medibank

Emyria

22/09/2025 01:39

** Shares of Australia's Emyria EMD.AX rise as much as 6% to A$0.053, their highest level since August 28

** The early-stage drug developer says health insurer Medibank Private MPL.AX signed a multi-year agreement to fund co's treatment programme for depression

** Shares of MPL were down 0.5% at A$4.865

** EMD up 50% YTD, including the session's moves

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))